Iovance Biotherapeutics, Inc. IOVA Non Cash Stock Based Compensation Included In Selling General And Administrative
Non Cash Stock Based Compensation Included In Selling General And Administrative at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept iova:NonCashStockBasedCompensationIncludedInSellingGeneralAndAdministrative.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s non cash stock based compensation included in selling general and administrative.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s non cash stock based compensation included in selling general and administrative?
- Iovance Biotherapeutics, Inc. (IOVA) reported non cash stock based compensation included in selling general and administrative of $5.13M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s non cash stock based compensation included in selling general and administrative changed year-over-year?
- Iovance Biotherapeutics, Inc.'s non cash stock based compensation included in selling general and administrative decreased by 51.5% year-over-year, from $10.58M to $5.13M.
- What does non cash stock based compensation included in selling general and administrative mean?
- This represents the non-cash expense associated with stock-based awards granted to administrative, sales, and marketing personnel. It reflects the cost of equity incentives used to attract and retain corporate and commercial staff. Analyzing this helps investors assess the overhead burden associated with supporting the company's administrative and commercial infrastructure.